Mohamad Hamad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohamad Hamad has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Gorka Orive
Basque Sustainable Pharmacy & Biotherapy Research Group School of Pharmacy University of the Basque Country (UPV/EHU) Vitoria‐Gasteiz Spain
2 shared publications - Taleb H. Al-Tel
Research Institute for Medical and Health Sciences University of Sharjah Sharjah 27272 United Arab Emirates
2 shared publications - Alexander D. Giddey
Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health, Dubai, UAE
1 shared publication Anusha Sebastian
Sharjah Institute for Medical Research, 27272, Sharjah, United Arab Emirates
1 shared publicationAshna Sulaiman
University of Sharjah
1 shared publication- Ashna Sulaiman
Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah P.O. Box 27227, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 22 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (12) , 2831
Multi-Omics Profiling of Candida albicans Grown on Solid Versus Liquid Media
Candida albicans is a common pathogenic fungus that presents a challenge to healthcare facilities. It can switch between a yeast cell form that diffuses through the bloodstream to colonize internal organs and a filamentous form that penetrates host mucosa. Understanding the pathogen’s strategies for environmental adaptation and, ultimately, survival, is crucial. As a complementary study, herein, a multi-omics analysis was performed using high-resolution timsTOF MS to compare the proteomes and metabolomes of Wild Type (WT) Candida albicans (strain DK318) grown on agar plates versus liquid media. Proteomic analysis revealed a total of 1793 proteins and 15,013 peptides. Out of the 1403 identified proteins, 313 proteins were significantly differentially abundant with a p-value < 0.05. Of these, 156 and 157 proteins were significantly increased in liquid and solid media, respectively. Metabolomics analysis identified 192 metabolites in total. The majority (42/48) of the significantly altered metabolites (p-value 0.05 FDR, FC 1.5), mainly amino acids, were significantly higher in solid media, while only 2 metabolites were significantly higher in liquid media. The combined multi-omics analysis provides insight into adaptative morphological changes supporting Candida albicans’ life cycle and identifies crucial virulence factors during biofilm formation and bloodstream infection.
- 22 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (12) , 2831
Open AccessMulti-Omics Profiling of Candida albicans Grown on Solid Versus Liquid Media
Candida albicans is a common pathogenic fungus that presents a challenge to healthcare facilities. It can switch between a yeast cell form that diffuses through the bloodstream to colonize internal organs and a filamentous form that penetrates host mucosa. Understanding the pathogen’s strategies for environmental adaptation and, ultimately, survival, is crucial. As a complementary study, herein, a multi-omics analysis was performed using high-resolution timsTOF MS to compare the proteomes and metabolomes of Wild Type (WT) Candida albicans (strain DK318) grown on agar plates versus liquid media. Proteomic analysis revealed a total of 1793 proteins and 15,013 peptides. Out of the 1403 identified proteins, 313 proteins were significantly differentially abundant with a p-value < 0.05. Of these, 156 and 157 proteins were significantly increased in liquid and solid media, respectively. Metabolomics analysis identified 192 metabolites in total. The majority (42/48) of the significantly altered metabolites (p-value 0.05 FDR, FC 1.5), mainly amino acids, were significantly higher in solid media, while only 2 metabolites were significantly higher in liquid media. The combined multi-omics analysis provides insight into adaptative morphological changes supporting Candida albicans’ life cycle and identifies crucial virulence factors during biofilm formation and bloodstream infection.
- Open Access
- 29 March 2023
- Published by Springer Nature in Research Square
Antimicrobial activity of nature-inspired molecules against multidrug resistant bacteria
Multidrug-resistant bacterial infections present a serious challenge to global health. In addition to the spread of antibiotic resistance, some bacteria can form persister cells which are tolerant to most antibiotics and can lead to treatment failure or relapse. In the present work, we report the discovery of a new class of small molecules with potent antimicrobial activity against Gram-positive bacteria and moderate activity against Gram negative drug resistant bacterial pathogens. The lead compound SIMR 2404 had a minimal inhibitory concentration (MIC) of 2 µg/ml against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate Staphylococcus aureus (VISA). The MIC values against Gram negative bacteria such as Escherichia coli and Actinobacteria baumannii were between 8–32 µg/ml. Time kill experiments show that compound SIMR 2404 can rapidly kill tested bacteria. Compound SIMR 2404 was also found to rapidly kill MRSA persisters which display high levels of tolerance to conventional antibiotics. In antibiotic evolution experiments, MRSA quickly developed resistance to ciprofloxacin but failed to develop resistance to compound SIMR 2404 even after 24 serial passages. The rapid antibacterial activity against both active and persister MRSA and to a lesser extent against Gram negative bacteria, suggest the potential of these molecules for further evaluation as antibacterial agents.
- 29 March 2023
- Published by Springer Nature in Research Square
Open AccessAntimicrobial activity of nature-inspired molecules against multidrug resistant bacteria
Multidrug-resistant bacterial infections present a serious challenge to global health. In addition to the spread of antibiotic resistance, some bacteria can form persister cells which are tolerant to most antibiotics and can lead to treatment failure or relapse. In the present work, we report the discovery of a new class of small molecules with potent antimicrobial activity against Gram-positive bacteria and moderate activity against Gram negative drug resistant bacterial pathogens. The lead compound SIMR 2404 had a minimal inhibitory concentration (MIC) of 2 µg/ml against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate Staphylococcus aureus (VISA). The MIC values against Gram negative bacteria such as Escherichia coli and Actinobacteria baumannii were between 8–32 µg/ml. Time kill experiments show that compound SIMR 2404 can rapidly kill tested bacteria. Compound SIMR 2404 was also found to rapidly kill MRSA persisters which display high levels of tolerance to conventional antibiotics. In antibiotic evolution experiments, MRSA quickly developed resistance to ciprofloxacin but failed to develop resistance to compound SIMR 2404 even after 24 serial passages. The rapid antibacterial activity against both active and persister MRSA and to a lesser extent against Gram negative bacteria, suggest the potential of these molecules for further evaluation as antibacterial agents.
- 1 November 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 223, 113639
Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise
- 1 November 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 223, 113639
Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise
- 1 December 2019
- Published by Elsevier in Drug Discovery Today
- Vol. 24 (12) , 2225-2228
Superbugs but no drugs: steps in averting a post-antibiotic era
- 1 December 2019
- Published by Elsevier in Drug Discovery Today
- Vol. 24 (12) , 2225-2228
Superbugs but no drugs: steps in averting a post-antibiotic era